CCC Project- Acute Coronary Syndrome
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02306616 |
Recruitment Status :
Completed
First Posted : December 3, 2014
Last Update Posted : January 27, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Acute Coronary Syndrome |
Study Type : | Observational |
Actual Enrollment : | 124363 participants |
Observational Model: | Case-Only |
Time Perspective: | Retrospective |
Official Title: | Improving Care for Cardiovascular Disease in China: A Collaborative Project of AHA and CSC (CCC Project) - Acute Coronary Syndrome |
Study Start Date : | November 2014 |
Actual Primary Completion Date : | December 2020 |
Actual Study Completion Date : | December 2020 |

- The overall composite of 11 performance measures for ACS care [ Time Frame: Duration of hospital stay, an expected average of 1 week ]
Performance measures for ACS care including:
- Proportion of patients received aspirin at arrival
- Proportion of patients received fibrinolytic therapy within 30 mins (STEMI)
- Proportion of patients received primary percutaneous coronary intervention within 90 mins (STEMI)
- Proportion of patients received reperfusion therapy (STEMI)
- Proportion of patients with aspirin prescribed at discharge
- Proportion of patients with clopidogrel or other P2Y12 inhibitors prescribed at discharge
- Proportion of patients with beta-blocker prescribed at discharge
- Proportion of patients with statin prescribed at discharge
- Proportion of patients received evaluation of left ventricular systolic function
- Proportion of left ventricular systolic dysfunction patients with ACEI or ARB prescribed at discharge
- Proportion of patients received smoking cessation advice/ counseling

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
Hospitalized patients with discharge diagnosis as acute coronary syndrome (including STEMI, NSTEMI and UAP) in 150 tertiary and 100 secondary hospitals.
Exclusion Criteria:
None

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02306616
China | |
Beijing An Zhen Hospital | |
Beijing, China |
Principal Investigator: | Dong Zhao, Ph. D | Beijing Institute of Heart, Lung and Blood Vessel Diseases |
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Dong ZHAO, Principal Investigator, Beijing Institute of Heart, Lung and Blood Vessel Diseases |
ClinicalTrials.gov Identifier: | NCT02306616 |
Other Study ID Numbers: |
CCC-ACS-2014 |
First Posted: | December 3, 2014 Key Record Dates |
Last Update Posted: | January 27, 2021 |
Last Verified: | January 2021 |
Acute Coronary Syndrome Syndrome Disease Pathologic Processes |
Myocardial Ischemia Heart Diseases Cardiovascular Diseases Vascular Diseases |